FDA Expands Infant Formula Resources to Support Transparency and Access

FDA Enhances Resources Related to Infant Formula Oversight

The U.S. Food and Drug Administration has announced updates to its infant formula resources aimed at improving transparency, safety, and access for consumers and stakeholders.

The Agency stated that these enhancements are intended to provide clearer information about infant formula products, regulatory processes, and supply availability, while supporting ongoing efforts to strengthen oversight of this critical product category.

Key Updates from FDA

FDA’s actions include:

Expanding publicly available information on infant formula products
Improving communication around regulatory requirements and review processes
Enhancing resources related to product availability and supply
Providing additional tools to support stakeholder understanding

These updates are part of FDA’s broader effort to increase visibility into how infant formula is regulated and monitored.

Background

Infant formula remains a highly regulated product category due to its importance for infant nutrition and public health. FDA continues to evaluate its regulatory approach following recent supply chain disruptions and increased focus on product safety and availability.

What This Means for Industry

While the update does not introduce new regulatory requirements, it reflects continued FDA focus on:

Strengthening oversight of infant formula manufacturers
Increasing transparency in regulatory processes
Supporting supply chain stability and consumer access

Manufacturers and stakeholders may benefit from improved access to information and clearer communication from FDA.

EAS Perspective

FDA’s continued focus on infant formula underscores the importance of transparency and resilience in this category. Enhanced resources may support both regulatory understanding and industry preparedness.

EAS will continue monitoring FDA activity related to infant formula and provide updates as additional actions or guidance are released.

Source: FDA Constituent Update

Date: March, 2026

Posted in FDA and USDA Regulatory Update, Foods.